OTTOBOCK SE & CO KGAA (OBCK.DE) Stock Fundamental Analysis

FRA:OBCK • DE000BCK2223

57 EUR
+1.1 (+1.97%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

3

Overall OBCK gets a fundamental rating of 3 out of 10. We evaluated OBCK against 63 industry peers in the Health Care Equipment & Supplies industry. OBCK has a bad profitability rating. Also its financial health evaluation is rather negative. OBCK is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year OBCK was profitable.
  • OBCK had a positive operating cash flow in the past year.
OBCK.DE Yearly Net Income VS EBIT VS OCF VS FCFOBCK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • OBCK has a worse Return On Assets (1.49%) than 64.62% of its industry peers.
  • The Return On Equity of OBCK (13.19%) is better than 76.92% of its industry peers.
  • OBCK has a Return On Invested Capital of 5.74%. This is comparable to the rest of the industry: OBCK outperforms 49.23% of its industry peers.
Industry RankSector Rank
ROA 1.49%
ROE 13.19%
ROIC 5.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OBCK.DE Yearly ROA, ROE, ROICOBCK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 5 10 15 20

1.3 Margins

  • OBCK has a worse Profit Margin (1.88%) than 64.62% of its industry peers.
  • OBCK's Operating Margin of 10.37% is in line compared to the rest of the industry. OBCK outperforms 49.23% of its industry peers.
  • OBCK's Gross Margin of 50.59% is on the low side compared to the rest of the industry. OBCK is outperformed by 64.62% of its industry peers.
Industry RankSector Rank
OM 10.37%
PM (TTM) 1.88%
GM 50.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OBCK.DE Yearly Profit, Operating, Gross MarginsOBCK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

  • OBCK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • OBCK has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, OBCK has an improved debt to assets ratio.
OBCK.DE Yearly Shares OutstandingOBCK.DE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M
OBCK.DE Yearly Total Debt VS Total AssetsOBCK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • OBCK has an Altman-Z score of 2.39. This is not the best score and indicates that OBCK is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.39, OBCK is in line with its industry, outperforming 44.62% of the companies in the same industry.
  • OBCK has a debt to FCF ratio of 5.22. This is a neutral value as OBCK would need 5.22 years to pay back of all of its debts.
  • OBCK has a Debt to FCF ratio (5.22) which is in line with its industry peers.
  • A Debt/Equity ratio of 4.45 is on the high side and indicates that OBCK has dependencies on debt financing.
  • With a Debt to Equity ratio value of 4.45, OBCK is not doing good in the industry: 86.15% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.45
Debt/FCF 5.22
Altman-Z 2.39
ROIC/WACC0.91
WACC6.28%
OBCK.DE Yearly LT Debt VS Equity VS FCFOBCK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • OBCK has a Current Ratio of 1.02. This is a normal value and indicates that OBCK is financially healthy and should not expect problems in meeting its short term obligations.
  • OBCK's Current ratio of 1.02 is on the low side compared to the rest of the industry. OBCK is outperformed by 78.46% of its industry peers.
  • OBCK has a Quick Ratio of 1.02. This is a bad value and indicates that OBCK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.65, OBCK is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.65
OBCK.DE Yearly Current Assets VS Current LiabilitesOBCK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

  • OBCK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.36%.
  • OBCK shows a small growth in Revenue. In the last year, the Revenue has grown by 7.33%.
EPS 1Y (TTM)-38.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1627.44%
Revenue 1Y (TTM)7.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.96%

3.2 Future

  • OBCK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 98.50% yearly.
  • Based on estimates for the next years, OBCK will show a small growth in Revenue. The Revenue will grow by 6.91% on average per year.
EPS Next Y455.04%
EPS Next 2Y155.96%
EPS Next 3Y98.5%
EPS Next 5YN/A
Revenue Next Year6.07%
Revenue Next 2Y6.24%
Revenue Next 3Y6.91%
Revenue Next 5YN/A

3.3 Evolution

OBCK.DE Yearly Revenue VS EstimatesOBCK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 500M 1B 1.5B
OBCK.DE Yearly EPS VS EstimatesOBCK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 121.28, OBCK can be considered very expensive at the moment.
  • 66.15% of the companies in the same industry are cheaper than OBCK, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of OBCK to the average of the S&P500 Index (27.07), we can say OBCK is valued expensively.
  • A Price/Forward Earnings ratio of 18.43 indicates a rather expensive valuation of OBCK.
  • OBCK's Price/Forward Earnings is on the same level as the industry average.
  • OBCK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 121.28
Fwd PE 18.43
OBCK.DE Price Earnings VS Forward Price EarningsOBCK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, OBCK is valued a bit cheaper than the industry average as 64.62% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of OBCK indicates a rather cheap valuation: OBCK is cheaper than 87.69% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.79
EV/EBITDA 13.93
OBCK.DE Per share dataOBCK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as OBCK's earnings are expected to grow with 98.50% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y155.96%
EPS Next 3Y98.5%

0

5. Dividend

5.1 Amount

  • No dividends for OBCK!.
Industry RankSector Rank
Dividend Yield 0%

OTTOBOCK SE & CO KGAA

FRA:OBCK (2/27/2026, 7:00:00 PM)

57

+1.1 (+1.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)03-19
Inst Owners1.39%
Inst Owner ChangeN/A
Ins Owners3.47%
Ins Owner ChangeN/A
Market Cap3.65B
Revenue(TTM)1.60B
Net Income(TTM)30.20M
Analysts85
Price Target86.26 (51.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.42%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 121.28
Fwd PE 18.43
P/S 2.27
P/FCF 15.79
P/OCF 10.77
P/B 15.93
P/tB N/A
EV/EBITDA 13.93
EPS(TTM)0.47
EY0.82%
EPS(NY)3.09
Fwd EY5.42%
FCF(TTM)3.61
FCFY6.33%
OCF(TTM)5.29
OCFY9.28%
SpS25.08
BVpS3.58
TBVpS-9.34
PEG (NY)0.27
PEG (5Y)N/A
Graham Number6.15
Profitability
Industry RankSector Rank
ROA 1.49%
ROE 13.19%
ROCE 11.76%
ROIC 5.74%
ROICexc 6.14%
ROICexgc 16.4%
OM 10.37%
PM (TTM) 1.88%
GM 50.59%
FCFM 14.4%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 4.45
Debt/FCF 5.22
Debt/EBITDA 2.98
Cap/Depr 61.49%
Cap/Sales 6.71%
Interest Coverage 2.87
Cash Conversion 99.18%
Profit Quality 764.9%
Current Ratio 1.02
Quick Ratio 0.65
Altman-Z 2.39
F-ScoreN/A
WACC6.28%
ROIC/WACC0.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1627.44%
EPS Next Y455.04%
EPS Next 2Y155.96%
EPS Next 3Y98.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.96%
Revenue Next Year6.07%
Revenue Next 2Y6.24%
Revenue Next 3Y6.91%
Revenue Next 5YN/A
EBIT growth 1Y73.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.19%
EBIT Next 3Y46.18%
EBIT Next 5YN/A
FCF growth 1Y59.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.08%
OCF growth 3YN/A
OCF growth 5YN/A

OTTOBOCK SE & CO KGAA / OBCK.DE FAQ

Can you provide the ChartMill fundamental rating for OTTOBOCK SE & CO KGAA?

ChartMill assigns a fundamental rating of 3 / 10 to OBCK.DE.


What is the valuation status of OTTOBOCK SE & CO KGAA (OBCK.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to OTTOBOCK SE & CO KGAA (OBCK.DE). This can be considered as Fairly Valued.


How profitable is OTTOBOCK SE & CO KGAA (OBCK.DE) stock?

OTTOBOCK SE & CO KGAA (OBCK.DE) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for OBCK stock?

The Price/Earnings (PE) ratio for OTTOBOCK SE & CO KGAA (OBCK.DE) is 121.28 and the Price/Book (PB) ratio is 15.93.


Can you provide the expected EPS growth for OBCK stock?

The Earnings per Share (EPS) of OTTOBOCK SE & CO KGAA (OBCK.DE) is expected to grow by 455.04% in the next year.